News & Events
Combinostics to Showcase Comprehensive Solutions for the Entire Patient Care Pathway of Neurological Disorders at RSNA
New and existing tools, including cPET, cARIA, and the Dementia Differential Analysis report, extend Combinostics’ solution beyond neurological image quantification and support end-to-end workflows.
Fountain Health announces 100 percent coverage of Combinostics cMRI and cDSI. The company is now the first and only health insurance platform to provide complete coverage for the AI-enabled neurological imaging and decision support solutions.
Dr. Erik Post and Dr. Hans-Peter Huber have joined Combinostics as Group Chief Financial Officer (CFO) and Vice President of European Sales, respectively. Their contributions include considerable experience scaling software solutions.
Combinostics’ cDSI and cMRI Applications, Part of the cNeuro Platform, Receive EC-certification Under the EU’s Medical Device Regulation (MDR)
cNeuro® cDSI™ and cNeuro cMRI™ achieve EC-certification under MDR, ensuring continued delivery of services to European customers.
The latest version of cNeuro® includes the launch of the Dementia Differential Analysis report, new disease-specific reports, additional automated MRI quantifications and imaging biomarkers, and more.